Related Experiment Video
Updated: Jan 11, 2026

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS
Published on: February 21, 2011
Clinical measures associated with aspiration risk in multiple system atrophy: a cross-sectional study
Jun Tanimura1,2, Toshiyuki Yamamoto1, Yuji Takahashi1
1Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawa Higashicho, Kodaira, Tokyo 187-8502, Japan.
The Barthel index (BI) can help identify aspiration risk in multiple system atrophy (MSA) patients, especially those with the parkinsonian subtype. This measure may guide swallowing assessments, even without obvious dysphagia symptoms.
Area of Science:
- Neurology
- Swallowing Disorders
- Clinical Diagnostics
Background:
- Aspiration risk is a critical concern in Multiple System Atrophy (MSA) management.
- Identifying reliable clinical markers for aspiration is essential for timely intervention.
Purpose of the Study:
- To investigate the association between basic clinical measures (Barthel Index, UMSARS, DaT imaging) and aspiration risk in MSA patients.
- To evaluate the discriminative ability of these measures in identifying aspiration.
Main Methods:
- Cross-sectional study of 105 MSA patients undergoing videofluoroscopic swallowing examination (VF) and DaT imaging.
- Clinical measures (BI, UMSARS) assessed within 3 months of VF.
- Multivariable modified Poisson regression and ROC analyses used to assess associations and discriminative ability.
Main Results:
- 26.7% of MSA patients exhibited aspiration on VF.
- Lower BI and higher UMSARS scores were significantly associated with aspiration.
- BI demonstrated moderate discriminative ability for aspiration (AUC 0.77), particularly in the parkinsonian MSA subtype.
Conclusions:
- The Barthel Index (BI) shows potential as a clinical marker for aspiration risk in MSA.
- BI may aid in guiding swallowing assessments, especially for the parkinsonian MSA subtype, even with subtle dysphagia.
- These findings can inform clinical decision-making for MSA patient care.
Related Concept Videos
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Assessment of Airway, Skin Color, and Use of Accessory Muscles
Introduction
The initial evaluation of a patient's respiratory system...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Mitral Stenosis II: Clinical features and Diagnostic Tests

